TCRX logo

TCRX

TScan Therapeutics, Inc.NASDAQHealthcare
$1.01+2.97%ClosedMarket Cap: $57.5M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-05WedbushOutperform
2025-11-13HC Wainwright & Co.Buy
2025-11-04BTIGNeutral
2025-11-04NeedhamBuy
2025-05-07HC Wainwright & Co.Buy
2025-04-08NeedhamBuy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.87$8.1M4
Sun Dec 31$-0.81$26.6M3
Mon Dec 31$-0.60$49.0M1
Tue Dec 31$-0.36$85.8M1